Results 91 to 100 of about 122,153 (397)
The Medicalization of Cannabis [PDF]
, 2010 Annotated and edited transcript of a Witness Seminar held on 24 March 2009. Introduction by Professor Leslie Iversen.First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2010.©The Trustee of the Wellcome Trust, London, 2010 ...
Crowther, SM, Reynolds, LA, Tansey, EM
core
Cannabinoids and Pain: New Insights From Old Molecules
Frontiers in Pharmacology, 2018 Cannabis has been used for medicinal purposes for thousands of years. The prohibition of cannabis in the middle of the 20th century has arrested cannabis research.
S. Vučković +4 more
semanticscholar +1 more source
Cannabinoids in the Pathophysiology of Skin Inflammation
Molecules, 2020 Cannabinoids are increasingly-used substances in the treatment of chronic pain, some neuropsychiatric disorders and more recently, skin disorders with an inflammatory component.
C. Scheau +9 more
semanticscholar +1 more source
Cannabinoids for epilepsy [PDF]
Cochrane Database of Systematic Reviews, 2011 Marijuana appears to have anti-epileptic effects in animals. It is not currently known if it is effective in patients with epilepsy. Some states in the United States of America have explicitly approved its use for epilepsy.To assess the efficacy of marijuana, or one of marijuana's constituents in the treatment of people with epilepsy.We searched the ...
David, Gloss, Barbara, Vickrey
openaire +3 more sources
Journal of Cannabis Research, 2023 Introduction With the legalization of cannabis in multiple jurisdictions throughout the world, a larger proportion of the population consumes cannabis.
Erin G. Whynot +2 more
doaj +1 more source
Separations, 2023 Synthetic cannabinoids are a series of synthetic substances that mimic the effects of natural cannabinoids and produce a much stronger toxicity than natural cannabinoids, and they have become the most abused family of new psychoactive substances. A solid-
Jianbing Wu +7 more
doaj +1 more source
Neuroprotective Effect of Cannabidiol Against Rotenone in Hippocampal Neuron Culture
Chemistry – An Asian Journal, EarlyView.(–)‐Cannabidiol (CBD) protects primary hippocampal neurons from rotenone, a mitochondrial complex I inhibitor that causes cell death. CBD preserves neuronal viability and morphology, with antagonist assays showing that transient receptor potential vanilloid 1 (TRPV1) mediates this neuroprotective effect.
Seoin Yang +3 more
wiley +1 more source
Mobile EEG examination of putative biomarkers of mental health in individuals that use cannabis
NPP-Digital Psychiatry and NeuroscienceHealthy individuals that use cannabis are at greater risk of developing mental health conditions than those that do not use cannabis. Here, using mobile electroencephalography (EEG) in controlled laboratory settings, we examined two putative biomarkers ...
Conor H. Murray +2 more
doaj +1 more source
Cannabinoids and Viral Infections
Pharmaceuticals, 2010 Exogenous cannabinoids or receptor antagonists may influence many cellular and systemic host responses. The anti-inflammatory activity of cannabinoids may compromise host inflammatory responses to acute viral infections, but may be beneficial in ...
Carol Shoshkes Reiss
doaj +1 more source
Autism Research, EarlyView.ABSTRACT Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by social communication deficits, repetitive behaviors, and sensory abnormalities. Sodium valproate (VPA) exposure during embryonic development is a well‐established preclinical model for ASD, leading to increased oxidative stress in the developing brain, including ...
Karla C. M. Costa +13 more
wiley +1 more source